mRNA-1283.815
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
Phase 3
Completed
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 14246
- Registration Number
- NCT05815498
- Locations
- 🇺🇸
Mountain View Ogden Clinic/CCT Research, Pleasant View, Utah, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
🇺🇸J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath